India signs up for USD 200-million loan from World Bank for nutrition mission

New Delhi: India signed an agreement with the World Bank on Monday for a USD 200-million loan for the National Nutrition Mission (POSHAN Abhiyaan) to achieve its goal of reducing stunting in children aged 0-6 years from 38.4 per cent to 25 per cent by 2022.

The loan will support the first phase of scaling up of interventions in 315 districts across all states and union territories, according to an official statement.

POSHAN Abhiyaan was launched by Prime Minister Narendra Modi on March 8 in Jhunjhunu in Rajasthan.

A large component of POSHAN Abhiyaan involves gradual scaling-up of the interventions supported by the ongoing World Bank-assisted Integrated Child Development Services (ICDS) Systems Strengthening and Nutrition Improvement Project (ISSNIP) to all districts in the country over a three-year period.

With a focus on improving the coverage and quality of ICDS nutrition services to pregnant and lactating women and children under three years of age, the project will include investments in improving the skills and capacities of ICDS staff and community nutrition workers, and grievance redress and establishing mobile technology based tools for improved monitoring and management of services for better outreach to beneficiaries during the critical 1,000 day window for nutrition impact, the statement said.

The project will additionally ensure convergence of all nutrition-related schemes and provide performance-based incentives to states and community nutrition and health workers, facilitating a focus on results.

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

    HC-ordered expert panel for weight loss drug may be set up by mid-July

    HC-ordered expert panel for weight loss drug may be set up by mid-July